Ubiquitin-independent degradation of hepatitis C virus F protein

Journal of Virology

Volumn 83, Issue 2, 2009, Pages 612-621

  Yuksek, Kamile ^a   Chen, Wen Ling ^a   Chien, David ^b   Ou, Jing Hsiung James ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; GREEN FLUORESCENT PROTEIN; HEPATITIS C VIRUS F PROTEIN; LYSINE; PROTEASOME; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BIOCHEMISTRY; CELL LINE; CODON; CYTOLOGY; ENZYME REGULATION; GENE DELETION; GENE MAPPING; GENETICS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RIBOSOMAL FRAMESHIFTING; TEMPERATURE SENSITIVITY; VIRUS GENOME;

ANIMALS; ARTIFICIAL GENE FUSION; CELL LINE; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; MICE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; RECOMBINANT FUSION PROTEINS; SEQUENCE DELETION; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITIN; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS;

EID: 58149517677     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00832-08     Document Type: Article

References (61)

1. Asher, G., J. Lotem, L. Sachs, C. Kahana, and Y. Shaul. 2002. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc. Natl. Acad. Sci. USA 99:13125-13130.
2. Aviel, S., G. Winberg, M. Massucci, and A. Ciechanover. 2000. Degradation of the Epstein-Barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue. J. Biol. Chem. 275:23491-23499.
3. Bain, C., P. Parroche, J. P. Lavergne, B. Duverger, C. Vieux, V. Dubois, F. Komurian-Pradel, C. Trepo, L. Gebuhrer, G. Paranhos-Baccala, F. Penin, and G. Inchauspe. 2004. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection. J. Virol. 78:10460-10469.
4. Baril, M., and L. Brakier-Gingras. 2005. Translation of the F protein of hepatitis C virus is initiated at a non-AUG codon in a +1 reading frame relative to the polyprotein. Nucleic Acids Res. 33:1474-1486.
5. Bercovich, Z., Y. Rosenberg-Hasson, A. Ciechanover, and C. Kahana. 1989. Degradation of ornithine decarboxylase in reticulocyte lysate is ATP-dependent but ubiquitin-independent. J. Biol. Chem. 264:15949-15952.
6. Boulant, S., M. Becchi, F. Penin, and J. P. Lavergne. 2003. Unusual multiple recoding events leading to alternative forms of hepatitis C virus core protein from genotype 1b. J. Biol. Chem. 278:45785-45792.
7. Braun, B. C., M. Glickman, R. Kraft, B. Dahlmann, P. M. Kloetzel, D. Finley, and M. Schmidt. 1999. The base of the proteasome regulatory particle exhibits chaperone-like activity. Nat. Cell Biol. 1:221-226.
8. Breitschopf, K., E. Bengal, T. Ziv, A. Admon, and A. Ciechanover. 1998. A novel site for ubiquitination: the N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein. EMBO J. 17:5964-5973.
9. Chau, V., J. W. Tobias, A. Bachmair, D. Marriott, D. J. Ecker, D. K. Gonda, and A. Varshavsky. 1989. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 243:1576-1583.
10. Chen, X., L. F. Barton, Y. Chi, B. E. Clurman, and J. M. Roberts. 2007. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Mol. Cell 26:843-852.
11. Choi, J., Z. Xu, and J. H. Ou. 2003. Triple decoding of hepatitis C virus RNA by programmed translational frameshifting. Mol. Cell. Biol. 23:1489-1497.
12. Cohen, M., L. Bachmatov, Z. Ben-Ari, Y. Rotman, R. Tur-Kaspa, and R. Zemel. 2007. Development of specific antibodies to an ARF protein in treated patients with chronic HCV infection. Dig. Dis. Sci. 52:2427-2432.
13. Craiu, A., M. Gaczynska, T. Akopian, C. F. Gramm, G. Fenteany, A. L. Goldberg, and K. L. Rock. 1997. Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J. Biol. Chem. 272:13437-13445.
14. Finley, D., A. Ciechanover, and A. Varshavsky. 1984. Thermolability of ubiquitin-activating enzyme from the mammalian cell cycle mutant ts85. Cell 37:43-55.
15. Fiorucci, M., S. Boulant, A. Fournillier, J. D. Abraham, J. P. Lavergne, G. Paranhos-Baccala, G. Inchauspe, and C. Bain. 2007. Expression of the alternative reading frame protein of hepatitis C virus induces cytokines involved in hepatic injuries. J. Gen. Virol. 88:1149-1162.
16. Glickman, M. H., and A. Ciechanover. 2002. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82:373-428.
17. Groettrup, M., A. Soza, M. Eggers, L. Kuehn, T. P. Dick, H. Schild, H. G. Rammensee, U. H. Koszinowski, and P. M. Kloetzel. 1996. A role for the proteasome regulator PA28alpha in antigen presentation. Nature 381:166-168.
18. Groll, M., M. Bajorek, A. Kohler, L. Moroder, D. M. Rubin, R. Huber, M. H. Glickman, and D. Finley. 2000. A gated channel into the proteasome core particle. Nat. Struct. Biol. 7:1062-1067.
19. Haas, A. L., J. V. Warms, A. Hershko, and I. A. Rose. 1982. Ubiquitin-activating enzyme. Mechanism and role in protein-ubiquitin conjugation. J. Biol. Chem. 257:2543-2548.
20. Hershko, A., and A. Ciechanover. 1998. The ubiquitin system. Annu. Rev. Biochem. 67:425-479.
21. Hu, Z., Z. Zhang, E. Doo, O. Coux, A. L. Goldberg, and T. J. Liang. 1999. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J. Virol. 73:7231-7240.
22. Johnston, S. C., F. G. Whitby, C. Realini, M. Rechsteiner, and C. P. Hill. 1997. The proteasome 11S regulator subunit REG alpha (PA28 alpha) is a heptamer. Protein Sci. 6:2469-2473.
23. Kalejta, R. F., and T. Shenk. 2003. Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein. Proc. Natl. Acad. Sci. USA 100:3263-3268.
24. Kim, J. H., S. Kang, J. Kim, and B. Y. Ahn. 2003. Hepatitis B virus core protein stimulates the proteasome-mediated degradation of viral X protein. J. Virol. 77:7166-7173.
25. Komurian-Pradel, F., A. Rajoharison, J. L. Berland, V. Khouri, M. Perret, M. Van Roosmalen, S. Pol, F. Negro, and G. Paranhos-Baccala. 2004. Antigenic relevance of F protein in chronic hepatitis C virus infection. Hepatology 40:900-909.
26. Liu, C. W., M. J. Corboy, G. N. DeMartino, and P. J. Thomas. 2003. Endoproteolytic activity of the proteasome. Science 299:408-411.
27. Liu, C. W., L. Millen, T. B. Roman, H. Xiong, H. F. Gilbert, R. Noiva, G. N. DeMartino, and P. J. Thomas. 2002. Conformational remodeling of proteasomal substrates by PA700, the 19 S regulatory complex of the 26 S proteasome. J. Biol. Chem. 277:26815-26820.
28. Loetscher, P., G. Pratt, and M. Rechsteiner. 1991. The C terminus of mouse ornithine decarboxylase confers rapid degradation on dihydrofolate reductase. Support for the pest hypothesis. J. Biol. Chem. 266:11213- 11220.
29. Lu, W., A. Strohecker, and J. H. Ou Jh. 2001. Post-translational modification of the hepatitis C virus core protein by tissue transglutaminase. J. Biol. Chem. 276:47993-47999.
30. Ma, H. C., T. W. Lin, H. Li, S. M. Iguchi-Ariga, H. Ariga, Y. L. Chuang, J. H. Ou, and S. Y. Lo. 2008. Hepatitis C virus ARFP/F protein interacts with cellular MM-1 protein and enhances the gene trans-activation activity of c-Myc. J. Biomed Sci. 15:417-425.
31. McMullan, L. K., A. Grakoui, M. J. Evans, K. Mihalik, M. Puig, A. D. Branch, S. M. Feinstone, and C. M. Rice. 2007. Evidence for a functional RNA element in the hepatitis C virus core gene. Proc. Natl. Acad. Sci. USA 104:2879-2884.
32. Miller, C. L., and D. J. Pintel. 2001. The NS2 protein generated by the parvovirus minute virus of mice is degraded by the proteasome in a manner independent of ubiquitin chain elongation or activation. Virology 285:346-355.
33. Nandi, D., P. Tahiliani, A. Kumar, and D. Chandu. 2006. The ubiquitinproteasome system. J. Biosci. 31:137-155.
34. Palmer, A., G. G. Mason, J. M. Paramio, E. Knecht, and A. J. Rivett. 1994. Changes in proteasome localization during the cell cycle. Eur. J. Cell Biol. 64:163-175.
35. Palmer, A., A. J. Rivett, S. Thomson, K. B. Hendil, G. W. Butcher, G. Fuertes, and E. Knecht. 1996. Subpopulations of proteasomes in rat liver nuclei, microsomes and cytosol. Biochem. J. 316:401-407.
36. Ratinier, M., S. Boulant, C. Combet, P. Targett-Adams, J. McLauchlan, and J. P. Lavergne. 2008. Transcriptional slippage prompts recoding in alternate reading frames in the hepatitis C virus (HCV) core sequence from strain HCV-1. J. Gen. Virol. 89:1569-1578.
37. Reinstein, E., M. Scheffner, M. Oren, A. Ciechanover, and A. Schwartz. 2000. Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue. Oncogene 19:5944-5950.
38. Roussel, J., A. Pillez, C. Montpellier, G. Duverlie, A. Cahour, J. Dubuisson, and C. Wychowski. 2003. Characterization of the expression of the hepatitis C virus F protein. J. Gen. Virol. 84:1751-1759.
39. Salceda, S., and J. Caro. 1997. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272:22642-22647.
40. Seeger, M., K. Ferrell, R. Frank, and W. Dubiel. 1997. HIV-1 tat inhibits the 20 S proteasome and its 11 S regulator-mediated activation. J. Biol. Chem. 272:8145-8148.
41. Sheaff, R. J., J. D. Singer, J. Swanger, M. Smitherman, J. M. Roberts, and B. E. Clurman. 2000. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol. Cell 5:403-410.
42. Sir, D., W. L. Chen, J. Choi, T. Wakita, T. S. Yen, and J. H. Ou. 2008. Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response. Hepatology 48:1054-1061.
43. Takeuchi, J., H. Chen, and P. Coffino. 2007. Proteasome substrate degradation requires association plus extended peptide. EMBO J. 26:123-131.
44. Takeuchi, J., H. Chen, M. A. Hoyt, and P. Coffino. 2008. Structural elements of the ubiquitin-independent proteasome degron of ornithine decarboxylase. Biochem. J. 410:401-407.
45. Thrower, J. S., L. Hoffman, M. Rechsteiner, and C. M. Pickart. 2000. Recognition of the polyubiquitin proteolytic signal. EMBO J. 19:94-102.
46. Touitou, R., J. Richardson, S. Bose, M. Nakanishi, J. Rivett, and M. J. Allday. 2001. A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome. EMBO J. 20:2367-2375.
47. Troesch, M., E. Jalbert, S. Canobio, M. R. Boulassel, J. P. Routy, N. F. Bernard, J. Bruneau, N. Lapointe, M. Boucher, and H. Soudeyns. 2005. Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in subjects co-infected with hepatitis C virus and HIV-1. AIDS 19:775-784.
48. Varaklioti, A., N. Vassilaki, U. Georgopoulou, and P. Mavromara. 2002. Alternate translation occurs within the core coding region of the hepatitis C viral genome. J. Biol. Chem. 277:17713-17721.
49. Vassilaki, N., H. Boleti, and P. Mavromara. 2007. Expression studies of the core+1 protein of the hepatitis C virus 1a in mammalian cells. The influence of the core protein and proteasomes on the intracellular levels of core+1. FEBS J. 274:4057-4074.
50. Vassilaki, N., and P. Mavromara. 2003. Two alternative translation mechanisms are responsible for the expression of the HCV ARFP/F/core+1 coding open reading frame. J. Biol. Chem. 278:40503-40513.
51. Verma, R., L. Aravind, R. Oania, W. H. McDonald, J. R. Yates III, E. V. Koonin, and R. J. Deshaies. 2002. Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science 298:611-615.
52. Verma, R., R. Oania, J. Graumann, and R. J. Deshaies. 2004. Multiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin-proteasome system. Cell 118:99-110.
53. Viscidi, R. P., K. Mayur, H. M. Lederman, and A. D. Frankel. 1989. Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science 246:1606-1608.
54. Voges, D., P. Zwickl, and W. Baumeister. 1999. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem. 68:1015-1068.
55. Walewski, J. L., T. R. Keller, D. D. Stump, and A. D. Branch. 2001. Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. RNA 7:710-721.
56. Worthington, Z. E., and N. H. Carbonetti. 2007. Evading the proteasome: absence of lysine residues contributes to pertussis toxin activity by evasion of proteasome degradation. Infect. Immun. 75:2946-2953.
57. Wu, W. B., S. W. Shao, L. J. Zhao, J. Luan, J. Cao, J. Gao, S. Y. Zhu, and Z. T. Qi. 2007. Hepatitis C virus F protein up-regulates c-myc and downregulates p53 in human hepatoma HepG2 cells. Intervirology 50:341-346.
58. Xu, Z., J. Choi, W. Lu, and J. H. Ou. 2003. Hepatitis C virus F protein is a short-lived protein associated with the endoplasmic reticulum. J. Virol. 77:1578-1583.
59. Xu, Z., J. Choi, T. S. Yen, W. Lu, A. Strohecker, S. Govindarajan, D. Chien, M. J. Selby, and J. Ou. 2001. Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J. 20:3840-3848.
60. Zhang, M., C. M. Pickart, and P. Coffino. 2003. Determinants of proteasome recognition of ornithine decarboxylase, a ubiquitin-independent substrate. EMBO J. 22:1488-1496.
61. Zhang, Z., U. Protzer, Z. Hu, J. Jacob, and T. J. Liang. 2004. Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent manner. J. Virol. 78:4566-4572.